Building pharmaceutical outsourcing partnerships
Three stories of creating new therapeutic molecules
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
March 13, 2017 Cover
Volume 95, Issue 11
Three stories of creating new therapeutic molecules
Cover image:
Credit:
Three stories of creating new therapeutic molecules
C&EN’s curated list of places to go, people to see, and science to learn
While Trump takes aim at immigration, foreign trainees consider taking their talents elsewhere
Using electric current as a reagent streamlines reactions by avoiding hazardous reagents, generating less waste, and reducing cost
The companies hope to crack the biobased polyester problem by working with start-up Origin Materials
Northwestern professor discusses his chemistry legacy and hopes for scientists in China
The drug pentamidine disrupts the outer membrane of Gram-negative bacteria, allowing antibiotics inside to finish the job